title: Polysplenia Syndrome With Splenic and Skeletal Muscle Metastases From Thyroid Carcinoma Evaluated by FDG PET/CT: Case Report and Literature Review: A Care-Compliant Article.
abstract: Polysplenia syndrome (PSS) is a rare congenital abnormality. Metastases to spleen and skeletal muscle from differentiated thyroid cancer (DTC) are also extremely rare. Our case report aims to present an interesting case of PSS associated with splenic metastasis (SM) and skeletal muscle metastasis (SMM) from advanced papillary thyroid carcinoma which was evaluated on fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT). An 84-year-old Chinese man was admitted with the history of multiple enlarged masses in bilateral neck, right axillary, and inguinal areas for >2 months. The results of ultrasonography examination were highly suggestive of malignancy. The histological results of the following biopsy were consistent with papillary thyroid carcinoma with involvement of multiple regional lymph nodes. He was referred for an FDG PET/CT imaging to evaluate the situation. FDG PET/CT showed that an intense FDG-avid thyroid mass with widespread regional lymph node involvement and distant metastases in the body. Unexpected sites of metastases were detected in the spleens and skeletal muscles. Most interestingly, FDG PET/CT imaging also described the typical imaging findings of PSS including the 2 right-sided spleens, azygos and hemiazygos continuation of inferior vena cava (IVC), right-sided stomach, middle line liver, a short pancreas, preduodenal portal vein (PPV), and malrotation of gut. Whole body FDG PET/CT imaging can accurately evaluate the situation of DTC by detecting regional lymph node involvement, common and rare sites of distant metastases which are closely related to staging, management, and prognosis of this disease. Whole-body FDG PET/CT is also valuable in demonstrating the typical imaging features of PSS.
authors.affiliation: From the Department of Nuclear Medicine (Z-GL, Z-CL); and Department of Oncology (H-YM), Pingjin Hospital, Logistics University of Chinese People's Armed Police Force, Tianjin, People's Republic of China.
authors.forename: Zu-Gui
authors.initials: ZG
authors.lastname: Li
authors.forename: Zhi-Chun
authors.initials: ZC
authors.lastname: Lin
authors.forename: Hai-Yu
authors.initials: HY
authors.lastname: Mu
mesh_terms: D000369:Aged, 80 and over; D002277:Carcinoma / Q000150:complications / Q000556:secondary*; D019788:Fluorodeoxyglucose F18; D059446:Heterotaxy Syndrome / Q000150:complications*; D006801:Humans; D008297:Male; D064847:Multimodal Imaging; D019042:Muscle Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary; D018482:Muscle, Skeletal; D049268:Positron-Emission Tomography; D013160:Splenic Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary; D013964:Thyroid Neoplasms / Q000150:complications / Q000473:pathology*; D014057:Tomography, X-Ray Computed
chemical_list: D019788:Fluorodeoxyglucose F18
references.citation: Thyroid. 2008 Jun;18(6):663-4
references.pmid: 18578619
references.citation: Endocr Relat Cancer. 2011 Aug 30;18(5):R165-74
references.pmid: 21632805
references.citation: Indian J Surg. 2013 Jun;75(Suppl 1):236-7
references.pmid: 24426576
references.citation: Arch Pathol Lab Med. 2007 Jun;131(6):965-9
references.pmid: 17550328
references.citation: Cancer. 2008 Jan 1;112(1):193-203
references.pmid: 18040999
references.citation: Abdom Imaging. 1999 Mar-Apr;24(2):178-84
references.pmid: 10024407
references.citation: Indian J Nucl Med. 2010 Oct;25(4):171-2
references.pmid: 21712914
references.citation: J Med Case Rep. 2011 Oct 23;5:522
references.pmid: 22018056
references.citation: Singapore Med J. 2009 Feb;50(2):e61-4
references.pmid: 19296013
references.citation: Thyroid. 2011 Sep;21(9):1027-31
references.pmid: 21834676
references.citation: Clin Nucl Med. 2010 May;35(5):360-1
references.pmid: 20395716
references.citation: Pol J Radiol. 2014 Sep 13;79:311-4
references.pmid: 25237401
references.citation: Virchows Arch. 2006 Jun;448(6):857-61
references.pmid: 16568308
references.citation: Acta Pathol Microbiol Scand A. 1974 Jul;82(4):499-506
references.pmid: 4854372
references.citation: Intern Med. 2005 Aug;44(8):848-52
references.pmid: 16157985
references.citation: Clin Nucl Med. 2009 Mar;34(3):137-40
references.pmid: 19352273
references.citation: Acta Cytol. 2003 Nov-Dec;47(6):1116-8
references.pmid: 14674093
references.citation: Jpn J Clin Oncol. 2004 Apr;34(4):210-4
references.pmid: 15121758
references.citation: Eur Radiol. 2010 Mar;20(3):649-58
references.pmid: 19707767
references.citation: World J Gastroenterol. 2008 Nov 7;14(41):6418-20
references.pmid: 19009663
references.citation: Am J Transplant. 2014 Mar;14(3):724-8
references.pmid: 24502412
references.citation: Korean J Gastroenterol. 2012 Jul;60(1):47-51
references.pmid: 22832800
references.citation: Arch Pathol Lab Med. 2000 Apr;124(4):526-30
references.pmid: 10747308
references.citation: Mol Med. 2011 Mar-Apr;17(3-4):308-16
references.pmid: 21210073
references.citation: Korean J Radiol. 2013 Nov-Dec;14(6):905-13
references.pmid: 24265565
references.citation: Tumori. 1997 Jul-Aug;83(4):779-82
references.pmid: 9349322
references.citation: South Med J. 1992 Oct;85(10):1003-5
references.pmid: 1411716
references.citation: Jpn J Clin Oncol. 2000 Jan;30(1):27-9
references.pmid: 10770565
references.citation: N Engl J Med. 1998 Jan 29;338(5):297-306
references.pmid: 9445411
references.citation: Am J Med Genet. 1985 May;21(1):171-6
references.pmid: 4003441
references.citation: Med Hypotheses. 1980 Feb;6(2):133-7
references.pmid: 7393016
references.citation: Int Rev Exp Pathol. 1983;25:77-181
references.pmid: 6365823
references.citation: World J Gastroenterol. 2013 Aug 21;19(31):5199-203
references.pmid: 23964159
references.citation: Br J Radiol. 2011 Nov;84(1007):e217-20
references.pmid: 22011826
references.citation: Mol Clin Oncol. 2014 Sep;2(5):761-766
references.pmid: 25054043